Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate
Open Access
- 30 July 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 112 (5) , 787-792
- https://doi.org/10.1002/ijc.20460
Abstract
Prostate‐specific antigen (PSA) is a serine‐protease that, in addition to cleaving semenogelins in the seminal coagulum, is able to cleave extracellular matrix glycoproteins, thereby affecting cell migration and metastasis. We here report some new activities of PSA that deserve careful consideration in the cancer context: degradation of gelatin, degradation of type IV collagen in reconstituted basement membrane (Matrigel) and activation of progelatinase A (MMP‐2), but not pro‐MMP‐9, in a cell‐free system. Since consumption of green tea has been reported to lower the risk of prostate cancer, we investigated the effects of the major flavanol of green tea, (−)epigallocatechin‐3‐gallate (EGCG), on expression and activity of PSA by prostate carcinoma cells. In addition to restraint of PSA expression, EGCG was found to inhibit in a dose‐dependent manner all the above PSA activities, at concentrations lower than the cytotoxic serine‐protease inhibitor PMSF and close to levels measured in the serum following ingestion of green tea. The activity of PSA was suppressed also by the elastase released by the inflammatory leukocytes. These results highlight new PSA activities, suggest gelatin zymography as a new convenient assay for PSA, propose EGCG as natural inhibitor of prostate carcinoma aggressiveness, but also stimulate further investigation on the role of prostatic inflammation.Keywords
This publication has 38 references indexed in Scilit:
- Protective effect of green tea against prostate cancer: A case‐control study in southeast ChinaInternational Journal of Cancer, 2003
- Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial CellsJournal of Biological Chemistry, 2003
- The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors, which increase PSA secretion and modify actin cytoskeletonThe FASEB Journal, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- CONTAMINATION OF PURIFIED PROSTATE-SPECIFIC ANTIGEN PREPARATIONS BY KALLIKREIN hK2Journal of Urology, 1998
- Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallateCancer Letters, 1995
- Nutrition and prostate cancer: A proposal for dietary interventionNutrition and Cancer, 1994
- Transcriptional regulation of prostate kallikrein-like genes by androgenMolecular Endocrinology, 1992
- Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.Journal of Clinical Investigation, 1987
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980